1. Home
  2. FRPH vs CGEM Comparison

FRPH vs CGEM Comparison

Compare FRPH & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRPH
  • CGEM
  • Stock Information
  • Founded
  • FRPH 1986
  • CGEM 2016
  • Country
  • FRPH United States
  • CGEM United States
  • Employees
  • FRPH N/A
  • CGEM N/A
  • Industry
  • FRPH Real Estate
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • FRPH Finance
  • CGEM Health Care
  • Exchange
  • FRPH Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • FRPH 459.4M
  • CGEM 437.2M
  • IPO Year
  • FRPH N/A
  • CGEM 2021
  • Fundamental
  • Price
  • FRPH $25.04
  • CGEM $7.85
  • Analyst Decision
  • FRPH
  • CGEM Strong Buy
  • Analyst Count
  • FRPH 0
  • CGEM 7
  • Target Price
  • FRPH N/A
  • CGEM $26.00
  • AVG Volume (30 Days)
  • FRPH 53.3K
  • CGEM 1.5M
  • Earning Date
  • FRPH 11-10-2025
  • CGEM 11-07-2025
  • Dividend Yield
  • FRPH N/A
  • CGEM N/A
  • EPS Growth
  • FRPH N/A
  • CGEM N/A
  • EPS
  • FRPH 0.28
  • CGEM N/A
  • Revenue
  • FRPH $32,293,999.00
  • CGEM N/A
  • Revenue This Year
  • FRPH N/A
  • CGEM N/A
  • Revenue Next Year
  • FRPH N/A
  • CGEM N/A
  • P/E Ratio
  • FRPH $89.24
  • CGEM N/A
  • Revenue Growth
  • FRPH 3.18
  • CGEM N/A
  • 52 Week Low
  • FRPH $23.52
  • CGEM $5.68
  • 52 Week High
  • FRPH $33.00
  • CGEM $17.50
  • Technical
  • Relative Strength Index (RSI)
  • FRPH 52.08
  • CGEM 56.01
  • Support Level
  • FRPH $24.57
  • CGEM $7.69
  • Resistance Level
  • FRPH $25.55
  • CGEM $8.69
  • Average True Range (ATR)
  • FRPH 0.52
  • CGEM 0.63
  • MACD
  • FRPH 0.11
  • CGEM 0.08
  • Stochastic Oscillator
  • FRPH 68.85
  • CGEM 60.17

About FRPH FRP Holdings Inc.

FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: